Live
- Man attacked by sons for delaying marriage
- TG bags Best Inland Fisheries-2024 Nat’l Award
- Palle inspects arrangements in Puttaparthi
- Gold rates in Visakhapatnam today surges, check the rates on 23 November, 2024
- Gururaja School students win prizes in Balotsav-2024
- Barring Warangal, 5 airport projects fail to take wings
- KSS unit to be set up in Madakasira
- Narrow roads lead to frequent traffic jams in Kurnool
- Bengal bypolls: TMC leading in all six seats after 2nd round of counting
- Stimulating NREM sleep can boost cognitive function, memory
India to have coronavirus vaccine by 2020 end: Harsh Vardhan
Union Minister of Health and Family Welfare Harsh Vardhan
Union Minister of Health and Family Welfare Harsh Vardhan said on Saturday that the country will have a vaccine against the deadly coronavirus by the end of the year.
NEW DELHI: Union Minister of Health and Family Welfare Harsh Vardhan said on Saturday that the country will have a vaccine against the deadly coronavirus by the end of the year.
Speaking to reporters here, he said that a coronavirus vaccine is likely in the next 4-5 months.
"I hope that if everything goes well, India will have access to a coronavirus vaccine by the end of 2020," the minister tweeted later.
The Ministry of Health and Family Welfare said that one of the three Covid-19 vaccine candidates has entered the third phase of the pre-clinical human trial.
According to V.K. Paul, head of the national task force on Covid-19, the vaccine candidate entering the third phase has yielded encouraging results in the initial phases of its trial.
Paul said that the other two vaccines are currently in Phase-I or II of their pre-clinical trials.
However, they did not reveal the names of the vaccines while sharing the status of their testing phase.
While the officials did not reveal the names of the vaccine candidates while speaking about their testing phase, it could be gathered that the vaccine entering the third phase is Bharat Biotech's Covaxin, jointly developed with the Indian Council of Medical Research (ICMR).
India currently has three vaccine candidates for Covid-19 -- ChAdOx1, developed by Oxford University and manufactured jointly by the Serum Institute of India (SII), Pune, and AstraZeneca; Bharat Biotech's Covaxin, jointly developed with the Indian Council of Medical Research; and the third is ZycovD by Zydus Cadila.
The SII had earlier said of starting the Phase 2 trial of its Covid-19 vaccine this week.
It added that it has shortlisted 10 centres across India to host Phase 2 and 3 human clinical trials.
Meanwhile, Zydus Cadila administered the second dose of its Covid-19 vaccine a few days ago.
The developments on the vaccine came a day after the National Expert Group on Vaccine Administration met five domestic vaccine manufacturers to review the clinical trial stages of these candidates. The manufacturers included two whose products are not yet in the clinical trial stage in India.
Zydus Cadila had stated in the review meeting that it may be able to launch the vaccine by next year.
According to the Health Ministry, the country recorded 69,878 new coronavirus cases in the last 24 hours, taking the total tally to 29,75,701 on Saturday morning.
During this period, 945 people lost their lives due to Covid-19 infection, taking the death toll to 55,794.
